AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2022

May 19, 2022

33018_dirs_2022-05-19_268bde35-2f0e-4c71-90a6-dbdf488e54fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2022-05-17

Reporting Person: Schwartz Robert Harris (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-17	Stock Option (Right to Buy)	$49.39	A	122449	Acquired	2032-05-17	Common Stock (122449)	Direct

Footnotes

F1: 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.